Logo image of AXS.AS

ACCSYS TECHNOLOGIES PLC (AXS.AS) Stock Fundamental Analysis

AMS:AXS - Euronext Amsterdam - GB00BQQFX454 - Common Stock - Currency: EUR

0.543  +0 (+0.56%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AXS. AXS was compared to 10 industry peers in the Paper & Forest Products industry. While AXS seems to be doing ok healthwise, there are quite some concerns on its profitability. AXS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AXS has reported negative net income.
In the past year AXS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AXS reported negative net income in multiple years.
AXS had a positive operating cash flow in each of the past 5 years.
AXS.AS Yearly Net Income VS EBIT VS OCF VS FCFAXS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

The Return On Assets of AXS (-16.92%) is worse than 70.00% of its industry peers.
With a Return On Equity value of -35.12%, AXS is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
AXS's Return On Invested Capital of 2.34% is in line compared to the rest of the industry. AXS outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -16.92%
ROE -35.12%
ROIC 2.34%
ROA(3y)-8.3%
ROA(5y)-4.7%
ROE(3y)-15.07%
ROE(5y)-8.42%
ROIC(3y)N/A
ROIC(5y)N/A
AXS.AS Yearly ROA, ROE, ROICAXS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

Looking at the Operating Margin, with a value of 3.50%, AXS is in line with its industry, outperforming 60.00% of the companies in the same industry.
AXS has a Gross Margin (31.12%) which is in line with its industry peers.
In the last couple of years the Gross Margin of AXS has grown nicely.
Industry RankSector Rank
OM 3.5%
PM (TTM) N/A
GM 31.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y3.9%
AXS.AS Yearly Profit, Operating, Gross MarginsAXS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXS is destroying value.
Compared to 1 year ago, AXS has more shares outstanding
Compared to 5 years ago, AXS has more shares outstanding
The debt/assets ratio for AXS has been reduced compared to a year ago.
AXS.AS Yearly Shares OutstandingAXS.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AXS.AS Yearly Total Debt VS Total AssetsAXS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.47, we must say that AXS is in the distress zone and has some risk of bankruptcy.
AXS's Altman-Z score of 0.47 is on the low side compared to the rest of the industry. AXS is outperformed by 70.00% of its industry peers.
AXS has a debt to FCF ratio of 4.92. This is a neutral value as AXS would need 4.92 years to pay back of all of its debts.
AXS's Debt to FCF ratio of 4.92 is in line compared to the rest of the industry. AXS outperforms 60.00% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that AXS is somewhat dependend on debt financing.
AXS's Debt to Equity ratio of 0.70 is in line compared to the rest of the industry. AXS outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 4.92
Altman-Z 0.47
ROIC/WACC0.33
WACC7.07%
AXS.AS Yearly LT Debt VS Equity VS FCFAXS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

AXS has a Current Ratio of 2.03. This indicates that AXS is financially healthy and has no problem in meeting its short term obligations.
AXS has a better Current ratio (2.03) than 90.00% of its industry peers.
A Quick Ratio of 1.34 indicates that AXS should not have too much problems paying its short term obligations.
AXS has a better Quick ratio (1.34) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.34
AXS.AS Yearly Current Assets VS Current LiabilitesAXS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

AXS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.05%.
The Revenue for AXS has decreased by -21.31% in the past year. This is quite bad
AXS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.62% yearly.
EPS 1Y (TTM)-12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.89%
Revenue 1Y (TTM)-21.31%
Revenue growth 3Y10.91%
Revenue growth 5Y12.62%
Sales Q2Q%1.42%

3.2 Future

AXS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.77% yearly.
AXS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.47% yearly.
EPS Next Y-212.93%
EPS Next 2Y46.16%
EPS Next 3Y53.77%
EPS Next 5YN/A
Revenue Next Year-2.88%
Revenue Next 2Y2.32%
Revenue Next 3Y5.89%
Revenue Next 5Y5.47%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AXS.AS Yearly Revenue VS EstimatesAXS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
AXS.AS Yearly EPS VS EstimatesAXS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.05 -0.05 -0.1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AXS. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 105.44 indicates a quite expensive valuation of AXS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AXS indicates a slightly more expensive valuation: AXS is more expensive than 60.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of AXS to the average of the S&P500 Index (21.98), we can say AXS is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 105.44
AXS.AS Price Earnings VS Forward Price EarningsAXS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXS is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
AXS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 9.71
EV/EBITDA 11.98
AXS.AS Per share dataAXS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

AXS's earnings are expected to grow with 53.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.16%
EPS Next 3Y53.77%

0

5. Dividend

5.1 Amount

No dividends for AXS!.
Industry RankSector Rank
Dividend Yield N/A

ACCSYS TECHNOLOGIES PLC

AMS:AXS (3/26/2025, 7:00:00 PM)

0.543

+0 (+0.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)11-26 2024-11-26
Earnings (Next)06-24 2025-06-24/amc
Inst Owners39.62%
Inst Owner ChangeN/A
Ins Owners0.57%
Ins Owner ChangeN/A
Market Cap130.54M
Analysts85.45
Price Target0.96 (76.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.33%
PT rev (3m)11.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-32.92%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 105.44
P/S 0.95
P/FCF 9.71
P/OCF 8.54
P/B 1.44
P/tB 1.55
EV/EBITDA 11.98
EPS(TTM)-0.13
EYN/A
EPS(NY)0.01
Fwd EY0.95%
FCF(TTM)0.06
FCFY10.29%
OCF(TTM)0.06
OCFY11.71%
SpS0.57
BVpS0.38
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.92%
ROE -35.12%
ROCE 3.12%
ROIC 2.34%
ROICexc 2.82%
ROICexgc 2.97%
OM 3.5%
PM (TTM) N/A
GM 31.12%
FCFM 9.8%
ROA(3y)-8.3%
ROA(5y)-4.7%
ROE(3y)-15.07%
ROE(5y)-8.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y3.9%
F-Score3
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 4.92
Debt/EBITDA 4.43
Cap/Depr 19.53%
Cap/Sales 1.34%
Interest Coverage 2.15
Cash Conversion 107.28%
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.34
Altman-Z 0.47
F-Score3
WACC7.07%
ROIC/WACC0.33
Cap/Depr(3y)378.65%
Cap/Depr(5y)352.01%
Cap/Sales(3y)19.57%
Cap/Sales(5y)19.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.89%
EPS Next Y-212.93%
EPS Next 2Y46.16%
EPS Next 3Y53.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-21.31%
Revenue growth 3Y10.91%
Revenue growth 5Y12.62%
Sales Q2Q%1.42%
Revenue Next Year-2.88%
Revenue Next 2Y2.32%
Revenue Next 3Y5.89%
Revenue Next 5Y5.47%
EBIT growth 1Y-59.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year163.37%
EBIT Next 3Y79.86%
EBIT Next 5YN/A
FCF growth 1Y126.36%
FCF growth 3Y-22.01%
FCF growth 5YN/A
OCF growth 1Y3050.58%
OCF growth 3Y-29.11%
OCF growth 5Y88.8%